Literature DB >> 27002091

Response to Letters Regarding Article, "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis".

Marianna Fontana1, Silvia Pica1, Patricia Reant1, Amna Abdel-Gadir1, Thomas A Treibel1, Sanjay M Banypersad1, Viviana Maestrini1, William Barcella1, Stefania Rosmini1, Heerajnarain Bulluck1, Rabya H Sayed2, Ketna Patel2, Shameem Mamhood2, Chiara Bucciarelli-Ducci3, Carol J Whelan2, Anna S Herrey1, Helen J Lachmann2, Ashutosh D Wechalekar2, Charlotte H Manisty1, Eric B Schelbert4, Peter Kellman5, Julian D Gillmore2, Philip N Hawkins2, James C Moon1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27002091      PMCID： PMC4806551          DOI： 10.1161/CIRCULATIONAHA.116.021162

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

1.  Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.

Authors:  Arsene Mekinian; Christophe Lions; Xavier Leleu; Alain Duhamel; Nicolas Lamblin; Valerie Coiteux; Pascal De Groote; Pierre-Yves Hatron; Thierry Facon; Jean-Paul Beregi; Eric Hachulla; David Launay
Journal:  Am J Med       Date:  2010-09       Impact factor: 4.965

2.  Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.

Authors:  Bethany A Austin; W H Wilson Tang; E Rene Rodriguez; Carmela Tan; Scott D Flamm; David O Taylor; Randall C Starling; Milind Y Desai
Journal:  JACC Cardiovasc Imaging       Date:  2009-12

3.  Myocardial contraction fraction: a volumetric index of myocardial shortening by freehand three-dimensional echocardiography.

Authors:  Donald L King; Lyna El-Khoury Coffin; Mathew S Maurer
Journal:  J Am Coll Cardiol       Date:  2002-07-17       Impact factor: 24.094

4.  Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis.

Authors:  Frederick L Ruberg; Evan Appelbaum; Ravin Davidoff; Al Ozonoff; Kraig V Kissinger; Caitlin Harrigan; Martha Skinner; Warren J Manning
Journal:  Am J Cardiol       Date:  2008-12-25       Impact factor: 2.778

5.  Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up.

Authors:  Raymond Q Migrino; Richard Christenson; Aniko Szabo; Megan Bright; Seth Truran; Parameswaran Hari
Journal:  BMC Med Phys       Date:  2009-05-05

6.  Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis.

Authors:  Alicia M Maceira; Sanjay K Prasad; Philip N Hawkins; Michael Roughton; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2008-11-25       Impact factor: 5.364

7.  Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.

Authors:  Marianna Fontana; Silvia Pica; Patricia Reant; Amna Abdel-Gadir; Thomas A Treibel; Sanjay M Banypersad; Viviana Maestrini; William Barcella; Stefania Rosmini; Heerajnarain Bulluck; Rabya H Sayed; Ketna Patel; Shameem Mamhood; Chiara Bucciarelli-Ducci; Carol J Whelan; Anna S Herrey; Helen J Lachmann; Ashutosh D Wechalekar; Charlotte H Manisty; Eric B Schelbert; Peter Kellman; Julian D Gillmore; Philip N Hawkins; James C Moon
Journal:  Circulation       Date:  2015-09-11       Impact factor: 29.690
  7 in total
  3 in total

Review 1.  New Advanced Imaging Parameters and Biomarkers-A Step Forward in the Diagnosis and Prognosis of TTR Cardiomyopathy.

Authors:  Roxana Cristina Rimbas; Anca Balinisteanu; Stefania Lucia Magda; Simona Ionela Visoiu; Andrea Olivia Ciobanu; Elena Beganu; Alina Ioana Nicula; Dragos Vinereanu
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.964

2.  Myocardial iodine concentration measurement using dual-energy computed tomography for the diagnosis of cardiac amyloidosis: a pilot study.

Authors:  Virgile Chevance; Thibaud Damy; Vania Tacher; François Legou; Fourat Ridouani; Alain Luciani; Hicham Kobeiter; Alain Rahmouni; Jean-François Deux
Journal:  Eur Radiol       Date:  2017-08-10       Impact factor: 5.315

Review 3.  The Evolving Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Systemic Amyloidosis.

Authors:  Sanjay M Banypersad
Journal:  Magn Reson Insights       Date:  2019-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.